A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report

A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report

A 66-year-old female patient presenting with dysphagia was diagnosed with stage IV unresectable gastric cancer (cTxN+M1). Multiple liver metastases were identified. The patient subsequently underwent five courses of chemotherapy and immunotherapy, including the capecitabine plus oxaliplatin (XELOX)...

Full description

Saved in:
Bibliographic Details
Main Authors: Li-Ping Sheng, Yun-Lin Huang, Zhi Wang, Hai-Fang Zhang, Jin-Yan Zhang, Xiao-Yi Lei
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Conversion surgery
tislelizumab
R0 resection
unresectable gastric cancer
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2406061
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items